tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 103 are a BUY (84.43%), 1 are a SELL (0.82%), 18 are a HOLD (14.75%).
Analyst Brandon Folkes, currently employed carries an average stock price target met ratio of 32.36% that have a potential upside of 14.88% achieved within 190 days. Previously, Brandon Folkes worked at CANTOR FITZGERALD.
Brandon Folkes’s has documented 229 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on OMER, Omeros at 10-Nov-2023.
Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for COLL (COLLEGIUM PHARMACEUTICAL) at 1/6/2020. The price target of $24 was fulfilled within 9 days with a profit of $3.69 (18.17%) receiving and performance score of 20.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$0.41 (7.33%)
$8
2 years 8 months 27 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
$5.6
$0.01 (0.18%)
2 years 9 months 6 days ago
(15-Feb-2022)
1/1 (100%)
$0.04 (0.72%)
34
Hold
$4.5
$-1.09 (-19.50%)
2 years 10 months ago
(21-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
$6.25
$0.66 (11.81%)
$5
3 years 6 months 15 days ago
(06-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
5 years 8 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
What Year was the first public recommendation made by Brandon Folkes?
